Juvenile Idiopathic Arthritis for the Pediatric Orthopedic Surgeon.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31466663.
- Also identified by DOI 10.1016/j.ocl.2019.06.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Juvenile idiopathic arthritis includes conditions characterized by joint inflammation of unknown etiology lasting longer than 6 weeks in patients younger than 16 years. Diagnosis and medical management are complex and best coordinated by a pediatric rheumatologist. The mainstay of therapy is anti-inflammatory and biologic medications to control pain and joint inflammation. Orthopedic surgical treatment may be indicated for deformity, limb length inequality, or end-stage arthritis. Evaluation of the cervical spine and appropriate medication management in consultation with a patient's rheumatologist are essential in perioperative care. Preoperative planning should take into account patient deformity, contracture, small size, osteopenia, and medical comorbidities.
Medical subject headings
- Arthritis, Juvenile
- Combined Modality Therapy
- Patient-Centered Care